Based on these results, ovarian cancers were divided into six groups: (1) BRCA1 mutations, (2) BRCA1 epigenetic loss, (3) equivocal for BRCA1 loss, (4) high grade serous/undifferentiated cancers without BRCA1 loss, (5) BRCA2 mutations, and (6) clear cell, endometrioid, and low grade serous cancers. The gene discussed is BRCA1; the disease is ovarian cancer.